Zimmer Holdings, Inc.  

(Public, NYSE:ZMH)   Watch this stock  
Find more results for Zimmer Holdings�
115.65
+0.34 (0.29%)
Mar 26 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 114.66 - 116.62
52 week 90.48 - 121.84
Open 115.34
Vol / Avg. 793,707.00/1.14M
Mkt cap 19.60B
P/E 27.57
Div/yield 0.22/0.76
EPS 4.19
Shares 169.90M
Beta 0.91
Inst. own 87%
May 5, 2015
Zimmer Holdings Inc Annual Shareholders Meeting - 8:00AM EDT - Add to calendar
Apr 22, 2015
Q1 2015 Zimmer Holdings Inc Earnings Release (Estimated) - 7:30AM EDT - Add to calendar
Jan 29, 2015
Q4 2014 Zimmer Holdings Inc Earnings Call
Jan 29, 2015
Q4 2014 Zimmer Holdings Inc Earnings Release
Jan 13, 2015
Zimmer Holdings Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 12.80% 15.39%
Operating margin 18.46% 22.14%
EBITD margin - 37.81%
Return on average assets 6.50% 7.48%
Return on average equity 9.62% 11.24%
Employees 10,000 -
CDP Score - 58 E

Address

345 E Main St
WARSAW, IN 46580-2746
United States - Map
+1-574-2676131 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. The Company also provides other healthcare related services. The Company�s customers include orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories. The Company�s products include orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products.

Officers and directors

David C. Dvorak President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
James T. Crines Chief Financial Officer, Executive Vice President - Finance
Age: 55
Bio & Compensation  - Reuters
Joseph A. Cucolo President, Americas Sales
Age: 55
Bio & Compensation  - Reuters
Katarzyna Mazur-Hofsaess M.D., Ph.D. President, Europe, Middle East and Africa
Age: 51
Bio & Compensation  - Reuters
Stephen H. L. Ooi President, Asia Pacific
Age: 61
Bio & Compensation  - Reuters
Chad F. Phipps Senior Vice President, General Counsel, Secretary
Age: 43
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Derek M. Davis Vice President - Finance, Chief Accounting Officer, Corporate Controller
Age: 46
Bio & Compensation  - Reuters
John L. McGoldrick Independent Non-Executive Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Michael J. Farrell Director
Age: 42
Bio & Compensation  - Reuters
Christopher B. Begley Independent Director
Age: 62
Bio & Compensation  - Reuters